Back to top

Analyst Blog

Dialysis company Fresenius Medical Care (FMS - Snapshot Report) and Apollo Medical Holdings, Inc. (ApolloMed, AMEH) revealed an agreement under which ApolloMed subsidiary ApolloMed ACO is joining hands with Fresenius Medical Care. Their purpose will be to provide composite treatment for ApolloMed patients suffering from end stage renal disease (ESRD).

Based in Glendale, California, ApolloMed is a doctor driven composite health care provider. ApolloMed aims to provide top class, cost effective care.

ApolloMed ACO is teaming with Fresenius Medical Care to provide high quality medical attention required by ESRD patients. Patients with ESRD require highly coordinated care as they are likely to suffer from co-morbidities.

The two parties will share the management and cost savings emanating from the agreement. This agreement has been tailored after a 5-year demonstration project conducted by a subsidiary of Fresenius Medical Care with Medicare enrollees on dialysis.  

Fresenius Medical Care is a large provider of products and services for patients undergoing dialysis treatment. The company’s principal competitor in the U.S. is DaVita HealthCare Partners Inc. (DVA - Analyst Report), which provides dialysis services for patients suffering from chronic kidney failure or end stage renal disease. Fresenius Medical Care also competes with Baxter International Inc. (BAX - Analyst Report) in certain niches such as peritoneal dialysis products.

The company continues to register good operating results in the North American as well as overseas markets. The integration of acquisitions is also expected to be accretive to Fresenius Medical Care’s earnings in the near term. However, the contagion of lingering economic problems in Europe remains a matter of concern.

The stock carries a Zacks Rank #4 (Sell). HeartWare International Inc. (HTWR - Snapshot Report) carries a Zacks Rank #2 (Buy) and is expected to do well.

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
UNITED THER… UTHR 117.83 +28.51%
TRIQUINT SE… TQNT 20.67 +6.52%
RF MICRO DE… RFMD 12.47 +6.04%
VASCO DATA… VDSI 14.77 +4.68%
BANCO DO BR… BDORY 15.53 +3.95%